{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T01:25:58Z","timestamp":1786497958789,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03570-8","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T20:38:44Z","timestamp":1735591124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fatigue, pain and faecal incontinence in adult inflammatory bowel disease patients and the unmet need: a national cross-sectional survey"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-6076","authenticated-orcid":false,"given":"Ailsa","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-3554","authenticated-orcid":false,"given":"Laura","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5987-3063","authenticated-orcid":false,"given":"Fionn Cl\u00e9irigh","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-3983","authenticated-orcid":false,"given":"Thomas","family":"Hamborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-2083","authenticated-orcid":false,"given":"Sonia","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6452-6763","authenticated-orcid":false,"given":"Richard C. G.","family":"Pollok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-5508","authenticated-orcid":false,"given":"Imogen","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9673-8047","authenticated-orcid":false,"given":"Vari","family":"Wileman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2718-2065","authenticated-orcid":false,"given":"Qasim","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9889-1248","authenticated-orcid":false,"given":"Wladyslawa","family":"Czuber-Dochan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7964-7672","authenticated-orcid":false,"given":"Lesley","family":"Dibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-1304","authenticated-orcid":false,"given":"Borislava","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-3446","authenticated-orcid":false,"given":"Rona","family":"Moss-Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-7689","authenticated-orcid":false,"given":"Chris","family":"Roukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2259-0948","authenticated-orcid":false,"given":"Christine","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"3570_CR1","doi-asserted-by":"crossref","unstructured":"Wilson BS, Lonnfors S, Vermeire S, Greco M, Hommes DW, Bell C et al. The true impact of IBD: a European Crohn\u2019s and Ulcerative Colitis patient life impact survey 2010-11. 2012 2012.","DOI":"10.1016\/S1873-9946(12)60425-5"},{"issue":"12","key":"3570_CR2","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1080\/00365521.2018.1543451","volume":"53","author":"H Proudfoot","year":"2018","unstructured":"Proudfoot H, Norton C, Artom M, Didymus E, Kubasiewicz S, Khoshaba K. Systematic review: targets for health interventions for faecal incontinence in inflammatory bowel disease. Scand J Gastroenterol. 2018;53(12):1476\u201383.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"3570_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/ecco-jcc\/jjw029","volume":"10","author":"M Artom","year":"2016","unstructured":"Artom M, Czuber-Dochan W, Sturt J, Norton C. Targets for health interventions for inflammatory bowel disease-fatigue. J Crohn\u2019s Colitis. 2016;10(7):860\u20139.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3570_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/apt.14493","volume":"47","author":"L Sweeney","year":"2018","unstructured":"Sweeney L, Moss-Morris R, Czuber-Dochan W, Meade L, Chumbley G, Norton C. Systematic review: psychosocial factors associated with pain in inflammatory bowel disease. Aliment Pharmacol Ther. 2018;47:715\u201329.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"3570_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/WON.0b013e3182a9a8b5","volume":"40","author":"C Norton","year":"2013","unstructured":"Norton C, Dibley L. Help-seeking for fecal incontinence in people with inflammatory bowel disease. J Wound Ostomy Cont Nurs. 2013;40(6):631\u20138.","journal-title":"J Wound Ostomy Cont Nurs"},{"issue":"4","key":"3570_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/2049463719844539","volume":"13","author":"LH Sweeney","year":"2019","unstructured":"Sweeney LH, Moss-Morris R, Czuber-Dochan W, Belotti L, Kabeli Z, Norton C. It\u2019s about willpower in the end. You\u2019ve got to keep going: a qualitative study exploring the experience of pain in inflammatory bowel disease. Br J Pain. 2019;13(4):201\u201313. https:\/\/doi.org\/10.1177\/2049463719844539.","journal-title":"Br J Pain"},{"key":"3570_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.004","author":"W Czuber-Dochan","year":"2014","unstructured":"Czuber-Dochan W, Norton C, Bredin F, Darvell M, Nathan I, Terry H. Healthcare professionals\u2019 perceptions of fatigue experienced by people with IBD. J Crohn\u2019s Colitis. 2014. https:\/\/doi.org\/10.1016\/j.crohns.2014.01.004.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"3570_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ecco-jcc\/jjw144","volume":"11","author":"A Hart","year":"2017","unstructured":"Hart A, Lomer MC, Verjee A, Kemp K, Faiz O, Daly A, et al. What are the top 10 research priorities in the treatment of inflammatory bowel disease? A priority setting partnership with the James Lind Alliance? J Crohn\u2019s Colitis. 2017;11(2):204\u201311. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw144.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3570_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13870","author":"M Artom","year":"2016","unstructured":"Artom M, Czuber-Dochan W, Sturt J, Murrells T, Norton C. The contribution of clinical and psychosocial factors in inflammatory bowel disease-fatigue: a cross-sectional study. Aliment Pharmacol Ther. 2016. https:\/\/doi.org\/10.1111\/apt.13870.","journal-title":"Aliment Pharmacol Ther"},{"key":"3570_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa244","author":"S Tadbiri","year":"2021","unstructured":"Tadbiri S, Nachury M, Bouhnik Y, Serrero M, Hebuterne X, Roblin X, et al. The IBD-disk is a reliable tool to assess the daily-life burden of patinets with inflammatory bowel disease. J Crohn\u2019s Colitis. 2021. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa244.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3570_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/eeco-jcc\/jjv218","author":"D Farrell","year":"2016","unstructured":"Farrell D, McCarthy G, Savage E. Self-reported symptom burden in individiuals with inflammatory bowel disease. J Crohn\u2019s Colitis. 2016. https:\/\/doi.org\/10.1093\/eeco-jcc\/jjv218.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3570_CR12","doi-asserted-by":"publisher","unstructured":"Dibley L, Khoshaba B, Artom M, Van Loo V, Sweeney L, Syred J, et al. Patient strategies for managing the vicious cycle of fatigue, pain and urgency in inflammatory bowel disease: impact, planning and support. Dig Dis Sci. 2021;3330\u201342. https:\/\/doi.org\/10.1007\/s10620-020-06698-1.","DOI":"10.1007\/s10620-020-06698-1"},{"key":"3570_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07109-9","author":"S Fawson","year":"2021","unstructured":"Fawson S, Dibley L, Smith K, Batista J, Artom M, Windgassen S, et al. Developing an online programme for self-management of fatigue, pain and urgency in inflammatory bowel disease: patients\u2019 needs and wants Digestive. Dis Sci. 2021. https:\/\/doi.org\/10.1007\/s10620-021-07109-9.","journal-title":"Dis Sci"},{"issue":"11","key":"3570_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63(11):1179\u201394.","journal-title":"J Clin Epidemiol"},{"key":"3570_CR15","doi-asserted-by":"crossref","unstructured":"Spiegel BM, Hays RD, Bolus R et al. Development of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol. 2014;109:1804-14.","DOI":"10.1038\/ajg.2014.237"},{"key":"3570_CR16","doi-asserted-by":"publisher","unstructured":"Norton C, Syred J, Kerry S, Artom M, Sweeney L, Hart A, et al. Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency\/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial. Trials. 2021;22. https:\/\/doi.org\/10.1186\/s13063-021-05466-4).","DOI":"10.1186\/s13063-021-05466-4)"},{"issue":"10","key":"3570_CR17","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","volume":"36","author":"A Sharma","year":"2021","unstructured":"Sharma A, Duc N, Thang T, Nam N, Ng SC, Abbbs K, et al. A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021;36(10):3179\u201387.","journal-title":"J Gen Intern Med"},{"key":"3570_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/jan.12060","author":"W Czuber-Dochan","year":"2012","unstructured":"Czuber-Dochan W, Dibley L, Terry H, Ream E, Norton C. The experience of fatigue in people with inflammatory bowel disease: an exploratory study. J Adv Nurs. 2012. https:\/\/doi.org\/10.1111\/jan.12060.","journal-title":"J Adv Nurs"},{"issue":"7","key":"3570_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/MIB.0b013e318281327f","volume":"19","author":"L Dibley","year":"2013","unstructured":"Dibley L, Norton C. Experience of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19(7):1450\u201362.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"3570_CR20","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1007\/s10620-020-06698-1","volume":"66","author":"L Dibley","year":"2021","unstructured":"Dibley L, Khoshaba B, Artom M, Van Loo V, Sweeney L, Syred J, et al. Patient strategies for managing the vicious cycle of fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support. Dig Dis Sci. 2021;66(10):3330\u201342.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"3570_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jnu.12409","volume":"50","author":"S Conley","year":"2018","unstructured":"Conley S, Jeon S, Procter D, Sandler RS, Redeker NS. Longitudinal changes in symptom cluster membership in inflammatory bowel disease. J Nurs Scholarsh. 2018;50(5):473\u201381.","journal-title":"J Nurs Scholarsh"},{"issue":"3","key":"3570_CR22","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1503\/cmaj.110829","volume":"184","author":"L Manea","year":"2012","unstructured":"Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. Can Med Assoc J. 2012;184(3):E191\u20136.","journal-title":"Can Med Assoc J"},{"key":"3570_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.genhosppsych.2013.04.006","volume":"35","author":"R-D Kocalevent","year":"2013","unstructured":"Kocalevent R-D, Hinz A, Br\u00e4hler E. Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2013;35:551\u20135.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"3570_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B Lowe","year":"2008","unstructured":"Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the General Population. Med Care. 2008;46(3):266\u201374.","journal-title":"Med Care"},{"key":"3570_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpsychores.2016.06.001","volume":"87","author":"R Neuendorf","year":"2016","unstructured":"Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70\u201380.","journal-title":"J Psychosom Res"},{"key":"3570_CR26","doi-asserted-by":"publisher","unstructured":"Seaton N, Hudson J, Harding S, Norton S, Mondelli V, Jones ASK et al. Do interventions for mood improve inflammatory biomarkers in inflammatory bowel disease? a systematic review and meta-analysis. EBioMedicine. 2024;100:104910. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104910.","DOI":"10.1016\/j.ebiom.2023.104910"},{"key":"3570_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cgh.2015.12.045","volume":"14","author":"A Mikocka-Walus","year":"2016","unstructured":"Mikocka-Walus A, Pittet V, Rossel J-B, von Kanel R. Symptoms of depression and anxiety are independently associated with clinial recurrence of inflammatory bowel diesase. Clin Gastrenterology Hepatol. 2016;14:829\u201335.","journal-title":"Clin Gastrenterology Hepatol"},{"issue":"7","key":"3570_CR28","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1007\/s10620-021-07109-9","volume":"67","author":"S Fawson","year":"2022","unstructured":"Fawson S, Dibley L, Smith K, Batista J, Artom M, Windgassen S, et al. Developing an online program for self-management of fatigue, Pain, and urgency in inflammatory bowel disease: patients\u2019 needs and wants. Dig Dis Sci. 2022;67(7):2813\u201326.","journal-title":"Dig Dis Sci"},{"key":"3570_CR29","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1053\/j.gastro.2021.08.060","volume":"162","author":"L Keefer","year":"2022","unstructured":"Keefer L, Bedell A, Norton C, Hart A. How should pain, fatigue and emotional wellness be incorporated into treatment goals for optimal managment of inflammatory bowel disease? Gastroenterology. 2022;162:1439\u201351.","journal-title":"Gastroenterology"},{"key":"3570_CR30","doi-asserted-by":"publisher","unstructured":"Farrell D, Artom M, Czuber-Dochan W, Jelsness-Jorgensen L-P, Norton C, Savage E. Interventions for fatigue in inflammatory bowel disease (Cochrane review). Cochrane Database of Systematic Reviews. 2020(issue 4. Art CD012005):https:\/\/doi.org\/10.1002\/14651858.CD012005.pub2","DOI":"10.1002\/14651858.CD012005.pub2"},{"key":"3570_CR31","doi-asserted-by":"publisher","unstructured":"Sinopoulou V, Gordon M, Akobeng AK, Gasparetto M, Sammaan M, Vasiliou J, et al. Interventions for the management of abdominal pain in Crohn\u2019s disease and inflammatory bowel disease (Review). Cochrane Database Syst Reviews. 2021;CD13531(11). https:\/\/doi.org\/10.1002\/14651848.","DOI":"10.1002\/14651848"},{"key":"3570_CR32","doi-asserted-by":"publisher","unstructured":"Sinopoulou V, Gordon M, Dovey TM, Akobeng AK. Interventions for the management of abdominal pain in ulcerative colitis (review). Cochrane Database Syst Reviews. 2021;CD013589(7). https:\/\/doi.org\/10.1002\/14651858.CD013589.pub2.","DOI":"10.1002\/14651858.CD013589.pub2"},{"key":"3570_CR33","doi-asserted-by":"crossref","unstructured":"Blackwell J, Saxena S, Jayasooriya N, Bottle A, Petersen I, Hotopf M et al. Prevalence and duration of gastrointestinal symptoms before diagnosis of inflammatory bowel Disease and predictors of timely specialist review: a population-based study. J Crohns Colitis. 2020.","DOI":"10.1093\/ecco-jcc\/jjaa146"},{"key":"3570_CR34","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","volume":"63","author":"K Bodger","year":"2014","unstructured":"Bodger K, Ormerod C, Shackcloth D, Harrison M, IBD Control Collaborative. Development and validation of a rapid, generic measure of disease control from the patient\u2019s perspective: the IBD-control questionnaire. Gut. 2014;63:1092\u2013102.","journal-title":"Gut"},{"issue":"2","key":"3570_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00365521.2020.1857430","volume":"56","author":"ME de Jong","year":"2021","unstructured":"de Jong ME, Taal E, Thomas PWA, R\u00f6mkens TEH, Jansen JM, West RL, et al. Cross-cultural translation and validation of the IBD-control questionnaire in the Netherlands: a patient-reported outcome measure in inflammatory bowel disease. Scand J Gastroenterol. 2021;56(2):155\u201361. https:\/\/doi.org\/10.1080\/00365521.2020.1857430.","journal-title":"Scand J Gastroenterol"},{"key":"3570_CR36","doi-asserted-by":"crossref","unstructured":"Jairath V, Khanna R, Zou GY et al. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. Aliment Pharmacol Ther. 2015;42:1200\u201310.","DOI":"10.1111\/apt.13408"},{"key":"3570_CR37","doi-asserted-by":"crossref","unstructured":"Khanna R, Zou G, D\u2019Haens G et al. A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn\u2019s disease activity. Aliment Pharmacol Ther. 2015;41:77\u201386.","DOI":"10.1111\/apt.13001"},{"key":"3570_CR38","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336.","journal-title":"Qual Life Res"},{"issue":"10","key":"3570_CR39","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"9","key":"3570_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9 - validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03570-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T21:03:33Z","timestamp":1735592613000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03570-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5027352\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was received from North West - Greater Manchester West Research Ethics Committee (Reference no: 18\/NW\/0613) on 11th October 2018. Informed consent to participate was obtained from all participants either in writing (postal) or online before accessing the online version of the survey. The study conformed to the requirements of the Helsinki declaration and the principles of Good Clinical Practice (GCP).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ailsa Hart: has served as consultant, advisory board member or speaker for AbbVie, Arena, Atlantic, Bristol-Myers Squibb, Celgene, Celltrion, Falk, Galapogos, Lilly, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the Global Steering Committee for Genentech.Laura Miller: NoneFionn Cl\u00e9irigh B\u00fcttner: None.Thomas Hamborg: NoneSonia Saxena: is an NIHR Senior investigator, funded by the National Institute for Health Research (NIHR) School for Public Health Research Grant Reference Number NIHR 204000 and NIHR Northwest London Applied Research CollaborationRichard Pollok: has served as consultant, advisory board member, speaker and\/or received educational grants from Dr Falk, Pharmacosmos, Takeda, Janssen, Napp pharmaceuticals and Ferring pharmaceuticals.Imogen Stagg: NoneVari Wileman: NoneQasim Aziz: Funding as PI from Classado Biosciences Ltd; Takeda Pharmaceuticals and Dr Falk Pharma UK for commercial clinical trials. Wladyslawa Czuber-Dochan: Speaker fees from Dr Falk Pharma and research funding from Bristol Myers Squibb and Crohn\u2019s and Colitis UKLesley Dibley: funding to support research from Takeda, Janssen; speaker fees from Abbvie, Janssen and WedMD. BRUK advisory board. Borislava Mihaylova: None Rona Moss-Morris: NoneChris Roukas: NoneChristine Norton: Speaker fees from: Janssen, WebMD, Medscape, Merck Pharmaceutical; Tillotts Pharma UK. Pfizer advisory board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"481"}}